The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics